UNIGE document Scientific Article
previous document  unige:33112  next document
add to browser collection
Title

Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience

Authors
Taussky, Daniel
Published in International Journal of Radiation Oncology, Biology, Physics. 2004, vol. 58, no. 5, p. 1431-6
Abstract Accelerated schedules are effective in overcoming repopulation during radiotherapy (RT) for head-and-neck cancers, but their feasibility is compromised by increased toxicity. The therapeutic ratio may be particularly favorable for 5-week regimens. This study reports the 10-year experience of a single institution in the routine use of concomitant boost RT as standard radical treatment in all but the most favorable stage patients.
Keywords AdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Squamous Cell/drug therapy/radiotherapy/surgeryCause of DeathCisplatin/administration & dosageCombined Modality TherapyDose FractionationFeasibility StudiesFemaleFluorouracil/administration & dosageHead and Neck Neoplasms/drug therapy/radiotherapy/surgeryHumansMaleMiddle AgedStatistics as Topic
Identifiers
PMID: 15050320
Full text
Article (Published version) (71 Kb) - public document Free access
Structures
Research group Groupe Dulguerov Pavel (ORL et chirurgie cervico-faciale) (145)
Citation
(ISO format)
ALLAL, Abdelkarim Said et al. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. In: International Journal of Radiation Oncology, Biology, Physics, 2004, vol. 58, n° 5, p. 1431-6. https://archive-ouverte.unige.ch/unige:33112

239 hits

132 downloads

Update

Deposited on : 2014-01-10

Export document
Format :
Citation style :